Giant Cell Tumor of Bone: Clinical Trials

3 trials for Giant Cell Tumor of Bone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Giant Cell Tumor of Bone: new trials by email Literature Review of Giant Cell Tumor of Bone trials Research Report on Giant Cell Tumor of Bone

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone
Narlumosbart, Denosumab - Giant Cell Tumor of Bone
Phase 3Not yet recruitingShanghai JMT-Bio Inc.1462023-04-012023-04-19
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
Zoledronic Acid - Giant Cell Tumor of Bone
Phase 3RecruitingSt. Louis University1202018-05-032026-11-19
Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone
Denosumab - Giant Cell Tumor of Bone
Phase 3UnknownHebei Medical University Third Hospital302016-05-012017-08-24

Broader conditions

Giant Cell Tumors (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Bone Tissue (3)  ·  Neoplasms, Connective Tissue (3)  ·  Neoplasms, Connective and Soft Tissue (3)

Interventions

Denosumab (2)  ·  Zoledronic Acid (1)

Sponsors

Hebei Medical University Third Hospital (1)  ·  Shanghai JMT-Bio Inc. (1)  ·  St. Louis University (1)

Countries

China (2)  ·  Canada (1)  ·  United States (1)

Top investigators

Xiaohui Niu, B.M. (1)  ·  Zhuang Zhou, Ph.D (1)